Cosmas brings to RAVen over a decade of leadership experiences at the interface of basic science, drug development and clinical care. Harveys primary responsibility is to oversee all accounting related activities for the firm. Jaimie's primary responsibility is to conduct research and analysis for competitive landscapes of drugs and medical devices across a range of disease indications and capabilities. Prior to this, he was a Postdoctoral Fellow at NYU Medical School in the laboratory of Dr. Danny Reinberg, exploring the functional downstream consequences of changes to the histone posttranslational modification landscape on processes that require access to DNA, including the regulation of gene expression. Anurag holds a BSE in Biomedical Engineering and a BS in Economics from Duke University. Neil was a founder or founding team member of six companies incubated within RA Ventures, including Lusaris Therapeutics, Eliem Therapeutics ($ELYM), Aerovate Therapeutics ($AVTE), Imbria Pharmaceuticals, and Athenen Therapeutics (acquired by Eliem). Angela has a BA in Pre-Medicine and French Studies from the University of Minnesota. Matthew works on both public and private investments and serves as a Board Director for Cerebral Therapeutics, DTx Pharma, Emergence Therapeutics, Forge Biologics, Jnana Therapeutics, and Kira Pharmaceuticals. He was named an MIT Technology Review 100 innovators under 35 for his MIT Media Lab social enterprise, Dimagi, that has impacted millions with its mobile data collection platform. Henry has a BA in Biology & Economics from Dartmouth College. Kat has a BS in Business Administration, majoring in Accounting from the University of Minnesota, Carlson School of Management. Prior to this role, Tom conducted research and analysis for competitive landscapes of drugs and medical devices across a range of disease indications and capabilities as a Senior Research Assistant. Gabes primary responsibility at RA Capital is to create competitive landscapes of drugs and medical devices for disease indications and capabilities. Mariagrace has a BS in Sociology from Suffolk University. Michael Calore is the Director of Investor Relations at RA Capital Management. Garrett received a BS with honors from the California Institute of Technology while publishing his first paper with Dr. Paul H. Patterson, holds a PhD in Immunology from Stanford University, where he studied hematopoietic stem and progenitor cells with Dr. Irving L. Weissman, and completed his post-doctoral training at Childrens Hospital Boston/Harvard Medical School studying ES/iPSC specification to the hematopoietic fate with Dr. George Q. Daley. Neil Buckley is an EIR at RA Capital. Scott joins RA Ventures (RAVen) as Venture Partner and will be focusing on new company creation. Priscilla previously held a Senior Scientist role at Sanofi. A funny, joyous romance on the streets of south London, plus Jude Law is a menacing Captain Hook in the new Neverland coming-of-age adventure Simon Wardell Fri 28 Apr 2023 04.00 EDT She is a CPA. Christina is a Senior Science Writer at RA Capital Management. At Prevail, Emily led business functions including business development, strategy, commercialization, public relations, patient advocacy, and intellectual property, and co-led financings generating $250 million in proceeds, including the companys IPO in 2019. Benjamin Hicks is a Venture Operations Associate at RA Capital Management. Asthas previous experience includes Research Assistant roles at Clark University and Corbus Pharma. Daniel holds both a BS and MS degree in Microbiology and Immunology from McGill University. Tom holds a BS in Health Sciences with a minor in Journalism from Northeastern University. Prithviraj works on both public and private investments with a focus on Healthcare, Technology, and Services. Tess Cameron is a Principal on the Investment Team at RA Capital Management. He works closely with RA's Investment Team on novel drug discovery platforms with emphasis on computational chemistry and machine learning. Cristinas primary responsibility is to identifying compelling opportunities to help facilitate new company creation and early stage investing. Megans primary responsibility at RA Capital is to create competitive landscapes of drugs and medical devices for disease indications and capabilities. TJ is a Senior Fund Accountant at RA Capital Management. The market worked. Her primary responsibilities are to coordinate calendars, events, travel and meetings for the Venture Partners within RAVen. Tyler Kowalski is an InteractiveDesigner at RA Capital Management. He is also an Advisor to HotSpot Therapeutics and recently served on the Board of Directors at Research Alliance Corporation I (merged with POINT Biopharma) and at TetraGenetics (acquired by AbCellera). According to Famous Birthdays, Peter was born on June 14, 1984, which makes him 38 years old, going on 39 in 2023. Prior to Mirai Advisory, he held a Financial Analyst role at Wainwright Investment Counsel. From 2016-2017, Scott served as President of Sojournix, Inc., an asset-focused biopharmaceutical company that he co-founded and served as Board member until 2021. Angela's primary responsibilities at RAVen are to lead development and oversee implementation of best practices in clinical strategies in RA's newcos and portfolio companies. Jesse has more than a decade of discovery research and management experience, from early discovery through preclinical development. Brackett has a BS in Biology with a minor in Spanish from Davidson College. He also gained extensive legislative and public policy experience early in his career as a Legislative Aide to former United States Senator David Boren, and as a Domestic Policy Advisor to former Vice President Al Gore. He oversees the firm's financial functions, including middle office operations, accounting, valuation, tax and financial reporting. Cameron has a BA in Neurobiology from Harvard University. He completed his residency in internal medicine at Yale-New Haven Hospital and completed his clinical gastroenterology fellowship at Massachusetts General Hospital / Harvard Medical School as well post-doctoral training with Frederick Alt, an HHMI investigator, in molecular immunology. He most recently served as Chief Medical Officer for Rodin Therapeutics, where he led all clinical development activities from first-in-human through patient studies until the acquisition by Alkermes. Nadim completed his BS in Biology at Stony Brook University, received his PhD with Distinction in Microbiology at Columbia University, and was an NRSA Postdoctoral Fellow studying the cell biology of HCV in the laboratory of Nobel Prize winner Charles M. Rice at the Rockefeller University. Age 46 / Jul 1976. Mario is a Venture Partner and Head of Vaccines at RA Capital. Ernestos primary responsibility at RA Capital is to coordinate various technology related initiatives across the company and oversee their initiation, planning, and execution. Mario received postdoctoral training at the NIH and Mount Sinai School of Medicine in innate immunity and bioinformatics, earned a PhD in microbiology at University of Chile and a MS in Nuclear Physics. Mr. Grau earned his BA with High Honors from Davidson College, where he was awarded a Dana Honor Scholarship and elected to Phi Beta Kappa, and his MPhil, MA, and MAR degrees from Yale University, where he was awarded the Day Graduate Prize and was the recipient of a Mellon Fellowship in the Humanities. He is a member of the Advisory Boards of the Applied Biotechnology Laboratory at the Francis Crick Institute, the Center for Surgery,Innovation & Bioengineering at the Massachusetts General Hospital/Harvard MedicalSchool; the Chemical& Biomolecular Engineering Department of the University of Illinois and the Biomedical Engineering Departmentof Rutgers University. Sarah Reed is the General Counsel at RA Capital Management. Prior to RAVen, he was a member of the founding team and Chief Operating Officer at Catamaran Bio, a CAR-NK cell therapy company. Cristinas primary responsibilities are to drive internal and external strategic and diligence initiatives and oversee the workflow and professional development of TechAtlas Associates. He co-founded and runs the Boston-based investment firm RA Capital Management; writes and teaches about biomedical entrepreneurship and its potential to transform global health; serves on the boards of several public and private drug development companies; and lives in Massachusetts with his historian/equestrian wife, strong-willed children, and reasonably well-trained dog. Jeff Breay is a Head Trader at RA Capital Management. Phi's primary responsibilities at RA Capital are to support the Operations team by coordinating calendars, events, and company meetings. Adisons primary responsibilities are to coordinate calendars, events, and company meetings for the Investment Team. GREENWICH Peter Crumbine, a mainstay of public service in Greenwich for decades whose level-headed, friendly and professional manner earned . Michael Varnum is a Research Assistant at RA Capital Management. Prior to MPM, Sarah was the General Counsel for Charles River Ventures and before that, at Palomar Medical Technologies. Prior to management consulting, Mr. Grau was Director of Marketing & Business Development at a clinical information technology startup. Not so long ago, his mother and father were not rich. Prior to RA, Megan worked as a Gastroenterology Fellow at University of Pittsburgh Medical Center and a Resident Physician, Internal Medicine, at Beth Israel Deaconess Medical Center. She holds a BBA in Marketing from Loyola University Maryland. Benjamins primary responsibilities at RA Capital are to coordinate various projects across the Venture Team and oversee their initiation, planning, and execution. Alex Martinez-Forte is an Analyst, Strategic Finance at RA Capital Management. Christy is a Senior Associate with the TechAtlas division of RA Capital Management. Kevin has a ME in Chemistry and Chemical Engineering from Chimie ParisTech in France, a MS in Biotechnology from the Royal Institute of Technology in Sweden, and a PhD in Physics and Chemistry from Paris Sciences et Lettres Research University in France. Previously, Zach covered the neurology, ophthalmology, and dermatology landscapes. Sarah began her legal career with Foley, Hoag, & Eliot LLP. Kathryn Meng is an Investment Director within the Planetary Health division of RA Capital. She was also an Entrepreneurial Fellow at VentureLabs for Flagship Pioneering. Prior to RA, Kevin was a postdoctoral associate at the Broad Institute of MIT and Harvard and an EMBO fellow. Prior to joining RA, Kyle was a Partner at Breakthrough Energy Ventures (BEV), where he led investments and served on company boards that span the utilities, energy storage, chemicals, agriculture, automotive, recycling, and consumer products sectors. Her graduate research investigated inhibitors of influenza virus and characterizing hydrophobic polycationic antimicrobial surfaces. Monicas primary responsibilities are to drive internal and external strategic and diligence initiatives and oversee the workflow and professional development of TechAtlas Associates. He previously worked as a Software Engineer for several companies, including Autodesk, the Advisory Board Company, and Maveric Systems. His doctoral research focused on breast cancer metastasis. James McArthur is an Advisor for RA Capital Management. In this role, he works closely with the RA Venture team to evaluate and incubate early-stage therapeutic programs. "He'll be 86 by the time it's over," said a woman in her 50s, noting the age Biden would be if he wins re-election and serves out a second term. Michaels primary responsibility at RA Capital is to start and maintain relationships with current and potential investors. Alexs primary responsibilities at RA Capital are to work closely with the Investment Team to originate conviction in potential investments by identifying breakthroughs and putting data into context, as well as advising RA's portfolio companies on many aspects of program and pipeline strategy.
Private Equity Capital Call Journal Entry,
What Happened On Utica Ave Today,
Do Roadrunners Attack Dogs,
Why Was Escaping Polygamy Cancelled,
Martha Speaks Voice Actress,
Articles P